Extra-tumoral breast tissue in breast cancer patients: Variations with steroid contraceptive use
Artículo
Open/ Download
Publication date
2006Metadata
Show full item record
Cómo citar
Vamre, Tone B.Aaman
Cómo citar
Extra-tumoral breast tissue in breast cancer patients: Variations with steroid contraceptive use
Author
Abstract
The association between oral contraceptive (OC) use and benign breast changes in extra-tumoral breast tissue was studied histologically in 1,503 breast cancer patients from The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. The occurrence of ductal hyperplasia, ductal atypia, sclerosing adenosis, cysts, apocrine metaplasia, apocrine hyperplasia, apocrine atypia, adenosis, lobular atypia, duct ectasia, calcifications, inflammatory reaction, lactational metaplasia and a high epithelial-stromal ratio was graded semi-quantitatively. Prevalence odds ratio (POR) for each histologic variable was calculated by logistic regression analyses. Patients who had ever used OC had lower occurrence of ductal hyperplasia than never users (POR 0.72 (95% CI 0.52-0.99)). Current use and more than 8 years of use was also associated with a lower prevalence of ductal hyperplasia (POR 0.40 (0.20-0.81) and POR 0.33 (0.17-0.64), respectively). Age > 35 years at first use was associated with inc
Indexation
Artículo de publicación SCOPUS
Identifier
URI: https://repositorio.uchile.cl/handle/2250/164143
DOI: 10.1002/ijc.21697
ISSN: 00207136
10970215
Quote Item
International Journal of Cancer, Volumen 118, Issue 11, 2018, Pages 2827-2831
Collections